Researchers are calling for more studies to determine whether lymphovenous anastomosis (LVA), a surgical procedure that helps clear molecular waste from the brain, might benefit people with Alzheimer’s disease.

“LVA represents a novel therapeutic strategy that may complement existing treatments, offering new hope for addressing the [disease biology] of [Alzheimer’s disease]. Through collaborative, long-term clinical trials, LVA may emerge not only as an adjunct to current [Alzheimer’s] therapies but also as a potential treatment avenue for other neurodegenerative diseases,” Khong Yik Chew, MD, a senior consultant at Singapore General Hospital, said in a press release.

Read more HERE